AL Capital Holdings 2016 Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
CPHO-M
IL0010843675
Pharmaceuticals
Sales 2022 | 49.3 18.49K 3.93K | Sales 2023 | 44.23 16.59K 3.53K | Capitalization | 25.49M 9.56B 2.03B |
---|---|---|---|---|---|
Net income 2022 | -48M -18B -3.83B | Net income 2023 | -88M -33B -7.02B | EV / Sales 2022 | 1,234,605 x |
Net Debt 2022 | 17.5M 6.56B 1.4B | Net Debt 2023 | 13.42M 5.03B 1.07B | EV / Sales 2023 | 879,698 x |
P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.69% |
Managers | Title | Age | Since |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 14/02/15 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
1st Jan change | Capi. | |
---|---|---|
+40.83% | 4.18B | |
+141.02% | 2.25B | |
+109.52% | 68.65M | |
+161.54% | 45.57M |